Web13 feb. 2024 · MMF was better tolerated than cyclophosphamide based on a longer time to patient withdrawal and a lower incidence of leukopenia and thrombocytopenia. ... Concomitant glucocorticoids were permitted in doses equivalent to ≤10 mg/day of prednisone. Outcomes at 12 months were:
Combination therapy with mycophenolate mofetil and prednisone …
WebOral prednisone can result in improved pulmonary function, particularly when used at an early ... Q16.6 Several studies have demonstrated the efficacy of MMF in the treatment of interstitial lung disease associated with diffuse systemic sclerosis, 90–94 and some consider it a first-line agent. 95 Studies regarding treatment for cutaneous ... Web7 jan. 2024 · Drug: Obinutuzumab Drug: MMF Drug: Prednisone Drug: Methylprednisolone Drug: Acetaminophen Drug: Diphenhydramine Drug: Placebo Study Type Interventional Enrollment (Anticipated) 252 Phase Phase 3 Contacts and Locations This section provides the contact details for those conducting the study, and information on where this study is … consultation hornu
Efficacy and safety of mycophenolate mofetil in patients with IgA ...
WebMMF is frequently used in the U.K. as second-line treatment, she added, with retrospective data suggesting an efficacy rate of 50% to 80% of patients with good tolerability. In the … Web1 feb. 2024 · Twelve patients were treated with MMF alone (monotherapy) and fourteen were treated with MMF and prednisone concomitantly at some point during their … Webtriple therapy comprising CsA, MMF, and steroids (25). The rates of rejection observed in our study were lower than those reported in previous studies using anti-IL-2R mono-clonal antibodies. However, in this study, basiliximab was used in conjunction with triple therapy comprising CsA, MMF, and steroids, rather than in conjunction with the dual consultation hopital brugmann